What's new in inflammatory bowel disease in 2008?
作者信息
Baumgart Daniel C
机构信息
Division of Gastroenterology and Hepatology, Department of Medicine, Charite Medical Center-Virchow Hospital, Medical School of the Humboldt-University of Berlin, Augustenburger Platz 1, Berlin, Germany.
出版信息
World J Gastroenterol. 2008 Jan 21;14(3):329-30. doi: 10.3748/wjg.14.329.
Abstract
Ulcerative colitis and Crohn's disease represent the two major forms of inflammatory bowel disease. In this highlight topic series of articles we cover the latest developments in genetics and epidemiology, intestinal physiology, mucosal immunology, mechanisms of epithelial cell injury and restitution, current medical therapy, modern surgical management, important extra-intestinal complications such as primary sclerosing cholangitis, cholangiocellular carcinoma and autoimmune hepatitis as well as endoscopic and molecular screening, detection and prevention of small bowel and colorectal cancer.
摘要
相似文献
1
What's new in inflammatory bowel disease in 2008?
World J Gastroenterol. 2008 Jan 21;14(3):329-30. doi: 10.3748/wjg.14.329.
2
What's hot in inflammatory bowel disease in 2011?
World J Gastroenterol. 2011 Feb 7;17(5):545-6. doi: 10.3748/wjg.v17.i5.545.
3
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
EBioMedicine. 2015 Sep 2;2(10):1523-7. doi: 10.1016/j.ebiom.2015.08.041. eCollection 2015 Oct.
4
The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
J Crohns Colitis. 2013 Dec;7(11):e551-7. doi: 10.1016/j.crohns.2013.04.003. Epub 2013 Apr 23.
5
Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
J Korean Med Sci. 1992 Sep;7(3):221-35. doi: 10.3346/jkms.1992.7.3.221.
6
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956.
7
Cancer in inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):378-89. doi: 10.3748/wjg.14.378.
8
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Digestion. 2007;75(2-3):113-21. doi: 10.1159/000104731. Epub 2007 Jun 26.
9
Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
Gastroenterol Hepatol. 2019 May;42(5):316-325. doi: 10.1016/j.gastrohep.2019.02.004. Epub 2019 Apr 1.
10
Severe inflammatory bowel disease: medical management.
Dig Dis. 2003;21(1):46-53. doi: 10.1159/000071339.
引用本文的文献
1
Mucoadhesive carriers for oral drug delivery.
J Control Release. 2022 Nov;351:504-559. doi: 10.1016/j.jconrel.2022.09.024. Epub 2022 Sep 30.
2
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.
Drugs Context. 2019 Apr 29;8:212572. doi: 10.7573/dic.212572. eCollection 2019.
3
Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?
J Crohns Colitis. 2016 Mar;10(3):269-76. doi: 10.1093/ecco-jcc/jjv199. Epub 2015 Oct 29.
4
Is lymphatic status related to regression of inflammation in Crohn's disease?
World J Gastrointest Surg. 2012 Oct 27;4(10):228-33. doi: 10.4240/wjgs.v4.i10.228.
5
Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.
Dig Dis Sci. 2013 Feb;58(2):371-80. doi: 10.1007/s10620-012-2348-4. Epub 2012 Aug 24.
6
Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.
Anticancer Res. 2010 Sep;30(9):3345-53.
7
A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
Am J Pathol. 2010 Feb;176(2):952-67. doi: 10.2353/ajpath.2010.090622. Epub 2009 Dec 30.
本文引用的文献
1
Special issues in pediatric inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):413-20. doi: 10.3748/wjg.14.413.
2
Recent trends in the surgical management of inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):408-12. doi: 10.3748/wjg.14.408.
3
Role of the intestinal barrier in inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):401-7. doi: 10.3748/wjg.14.401.
4
Immunopathogenesis of inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):390-400. doi: 10.3748/wjg.14.390.
5
Cancer in inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):378-89. doi: 10.3748/wjg.14.378.
6
Treatment of inflammatory bowel disease: a review of medical therapy.
World J Gastroenterol. 2008 Jan 21;14(3):354-77. doi: 10.3748/wjg.14.354.
7
Epithelial restitution and wound healing in inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):348-53. doi: 10.3748/wjg.14.348.
8
Inflammatory bowel disease: genetic and epidemiologic considerations.
World J Gastroenterol. 2008 Jan 21;14(3):338-47. doi: 10.3748/wjg.14.338.
9
Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
World J Gastroenterol. 2008 Jan 21;14(3):331-7. doi: 10.3748/wjg.14.331.
10
WILHELM FABRY (1560-1624)--THE OTHER FABRICIUS.
JAMA. 1964 Dec 7;190:933. doi: 10.1001/jama.1964.03070230069025.
Zotero 插件